| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/22/2002 | US20020116729 Expression vector coding enzymatic polypeptide for use in the treatment psychological disorders |
| 08/22/2002 | US20020116723 Insect expression vectors |
| 08/22/2002 | US20020115850 Expression vector for use in generation of disease resistant plants |
| 08/22/2002 | US20020115846 Nucleotide sequences coding protein for use in human therapeutics and diagnostics |
| 08/22/2002 | US20020115845 Promoter |
| 08/22/2002 | US20020115844 Novel human lipase and polynucleotides encoding the same |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115842 Novel human proteases and polynucleotides encoding the same |
| 08/22/2002 | US20020115839 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of cell proliferative, differentiation and migration defects |
| 08/22/2002 | US20020115838 Nucleotide sequences coding enzymatic polypeptide for use in human therapeutics and diagnostics |
| 08/22/2002 | US20020115827 Stabilizaton of heat resistant protein; obtain protein, replace aspartic acids with glutamic acids, recover protein |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/22/2002 | US20020115701 Have antipyretic action, analgesic action, antiinflammatory action, and particularly, selective inhibitory action on cyclooxygenase-2; ketomethylene intermediates |
| 08/22/2002 | US20020115637 Carbohydrate inhibits degradation; storage stability; heat resistance |
| 08/22/2002 | US20020115630 Isolated nucleic acids molecules, designated 33449 nucleic acid molecules, which encode novel protease or S26 signal peptidase family members. Antitumor, -carcinogenic and -proliferative agents; kits |
| 08/22/2002 | US20020115628 Modulating the ability of a cell to affect the glycosylation state of a target selected from a lipid and a polypeptide by modulating the activity of an enzyme of either 47169 or 33935 protein; cell signaling; differentiation; tumorigenesis |
| 08/22/2002 | US20020115616 Inhibit beta-secretase to reduce beta amyloid peptide concentrations and reduce the amyloid plaques and neuro-fibrillary tangles; Alzheimer's disease; stroke; Down' syndrome; amyotrophic lateral sclerosis; brain disorders |
| 08/22/2002 | US20020115607 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); diagnosis, drug screening, animal models |
| 08/22/2002 | US20020115606 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); modulating, in a cell, a protein complex between PN7740 and ligand Fe65 or PSD95 |
| 08/22/2002 | US20020115600 Inhibitors of memapsin 2 and use thereof |
| 08/22/2002 | US20020115220 Plasmid for use as tools in the transformation of candida cells |
| 08/22/2002 | US20020115217 Detecting modulators of cell metabolisms; obtain cells, incubate with modulator, monitor gene expression, detect adjusted metabolism in cells |
| 08/22/2002 | US20020115212 Cell culture for use in the generation of antitumor agents |
| 08/22/2002 | US20020115207 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/22/2002 | US20020115194 Biopreparation of textiles at high temperatures |
| 08/22/2002 | US20020115191 KdtB |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115186 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/22/2002 | US20020115184 Antibiotic protein and method of production |
| 08/22/2002 | US20020115183 Enzymatic protien for us ein prevention of tumor metastasis |
| 08/22/2002 | US20020115182 Polypeptide having beta-fructofuranosidase activity |
| 08/22/2002 | US20020115181 Enzymatic polypeptide for use in paper making and animal feeds |
| 08/22/2002 | US20020115179 Peptide for use in the treatment of asthma, arthritis and respiratory disorders |
| 08/22/2002 | US20020115178 16816 and 16839, novel human phospholipase C molecules and uses therefor |
| 08/22/2002 | US20020115177 Regulation of human histone deacetylase |
| 08/22/2002 | US20020115176 Polypeptide for use in the diagnosis and treatment of asthma, and respiratory disorders |
| 08/22/2002 | US20020115175 Enzymatic polypeptide for use in the treatment of inflammation, reperfusion injury, viral diseases, allergies, infections, pain, autoimmune,cardiovascular, nervous system, kidney, urogenital, sexual, kidney disorders |
| 08/22/2002 | US20020115173 Short peptides from the 'A-region' of protein kinases which selectively modulate protein kinase activity |
| 08/22/2002 | US20020115170 Polypeptides having peroxidase activity and nucleic acids encoding same |
| 08/22/2002 | US20020115169 Preservation of enzyme activity in cells; obtain cells, extract proteins, incubate with nucleoprotein, monitor preferential enzymatic |
| 08/22/2002 | US20020115167 Isolation of drosophila and human polynucleotides encoding PAR-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 08/22/2002 | US20020115161 Polynucleotide sequenes coding polypeptide for use in generation of human medicine, therapeutic, foods and animal nutrients |
| 08/22/2002 | US20020115160 Nucleotide sequences coding enzymatic polypeptide for use in the generation of human medicines, therapeutics, foods and animal nutrients |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115147 Method for producing an active heterodimeric AMV-RT in prokaryotic cells |
| 08/22/2002 | US20020115146 Method of protein synthesis |
| 08/22/2002 | US20020115145 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/22/2002 | US20020115141 Method for improved production of cyanophycin and secondary products thereof |
| 08/22/2002 | US20020115137 22406, a novel human pyridoxal-phosphate dependent enzyme family member and uses therefor |
| 08/22/2002 | US20020115133 Cyclic lipopeptide acylase |
| 08/22/2002 | US20020115126 Cholesterol desaturases from ciliates, methods and uses |
| 08/22/2002 | US20020115120 Controlling polypetide activity in cell; obtain cell, incubate with modulator, monitor gene expression and protein activity |
| 08/22/2002 | US20020115119 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020115114 Detecting modulators of kinase activity; obtain enzymatic polypeptide, incubate with modulator, monitor binding activity of kinases |
| 08/22/2002 | US20020115108 Enzymes having high temperature polymerase activity and methods of use thereof |
| 08/22/2002 | US20020115100 Screening library for nucleotide sequences which code polypeptides with alpha glactosidase activity; obtain nucleotide sequences, screen library, detectand recover nucleotide sequence which share homology with alpha |
| 08/22/2002 | US20020115099 Enzymes having alpha-galactosidase activity and methods of use thereof |
| 08/22/2002 | US20020115097 Determining the number of thymidine-adenine repeats that correlates with the expression of the glucuronosyltransferase (UGT) gene |
| 08/22/2002 | US20020115075 Polypeptide for use in screening bactericides |
| 08/22/2002 | US20020115058 Methods for diagnosis and treatment of diseases associated with altered expression of Pik3r1 |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | US20020114811 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex |
| 08/22/2002 | US20020114810 Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114799 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020114797 Composition and methods for modulating the length of telomeres |
| 08/22/2002 | US20020114787 Tolerance to natural antibody antigens |
| 08/22/2002 | DE10106541A1 Enzympräparat und dessen Verwendung in der Gerberei Enzyme preparation and its use in tanning |
| 08/22/2002 | DE10100238A1 Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests A method for predicting the risk potential for cancer diseases and inflammatory bowel disease and related tests |
| 08/22/2002 | CA2854685A1 Optimized messenger rna |
| 08/22/2002 | CA2438590A1 Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1 |
| 08/22/2002 | CA2438433A1 Methods for the diagnosis and treatment of tumors employing the hepsin gene |
| 08/22/2002 | CA2438356A1 Improved method for production of secreted proteins in fungi |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2437887A1 Methods of using mammalian rnase h and compositions thereof |
| 08/22/2002 | CA2437873A1 Neurotonin and use thereof |
| 08/22/2002 | CA2437868A1 Expression of human milk proteins in transgenic plants |
| 08/22/2002 | CA2437863A1 Isoprenoid synthases |
| 08/22/2002 | CA2437819A1 Feed additive compositions and methods |
| 08/22/2002 | CA2437583A1 Dna markers for meat tenderness |
| 08/22/2002 | CA2437246A1 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/22/2002 | CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2433057A1 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use |
| 08/22/2002 | CA2432364A1 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | CA2425732A1 Optimized messenger rna |
| 08/21/2002 | EP1233072A1 Novel use of uridine diphosphate glucose 4-epimerase |
| 08/21/2002 | EP1233063A2 Transgenic animals containing a dominant negative mutant form of the p85 subunit of pi-3 kinase |
| 08/21/2002 | EP1233061A2 A method for cloning of a gene for pol I type DNA polymerase |
| 08/21/2002 | EP1233060A2 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1233057A1 Sterilized microbial cells |
| 08/21/2002 | EP1233021A2 An inhibitor of Beta amyloid cleavage enzyme |
| 08/21/2002 | EP1232285A1 CATALYTIC RNAs WITH AMINOACYLATION ACTIVITY |
| 08/21/2002 | EP1232278A1 MICROBIAL 9$g(a)-HYDROXYLATION OF STEROIDS |
| 08/21/2002 | EP1232274A2 Enhanced transgene expression by co-expression with a suppressor of post-transcriptional gene silencing (ptgs) |
| 08/21/2002 | EP1232270A1 IMPROVING DIDEOXYNUCLEOTIDE-TRIPHOSPHATE UTILIZATION BY THE HYPER-THERMOPHILIC DNA POLYMERASE FROM THE ARCHAEON i PYROCOCCUS FURIOSUS /i |
| 08/21/2002 | EP1232269A1 Method for purifying proteins |
| 08/21/2002 | EP1232268A2 Cytochrome p450 oxygenases and their uses |
| 08/21/2002 | EP1232263A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232254A1 Process for the production of a reversibly inactive acidified plasmin composition |